Genotyping Influences Outcome of Coronary Artery Stenting

• Status: Completed
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluated epidemiology and clinical outcome of clopidogrel related various genotyping in Korean patients who had undergone percutaneous coronary intervention as a all comer registry form.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Korea University Anam Hospital
• Treatments: Clopidogrel; Ticlopidine

Criteria

Inclusion Criteria:

• Written informed consent

• Older than 20 years

• All percutaneous coronary intervention patients within 1 month

Exclusion Criteria:

• Pregnancy

• Life expectancy below 1 year

• Known aspirin or clopidogrel allergy